Overall, retatrutide serves as a versatile experimental platform for studying integrated receptor signaling across metabolic tissues
Respiratory medicine case reports, 2020
Around 69% to 84% lost at least 10%, while approximately 30% to 57% achieved a weight reduction of 20% or more, depending on the maintenance dose
Other side effects are much more rare, such as pancreatitis (inflammation of the pancreas), changes in vision, hypoglycemia (low blood sugar), kidney problems, severe stomach pain and associated problems, gallbladder problems, and thyroid tumors, which are a potential but rare risk associated with Ozempic
If left untreated, it can get worse